Samer Ellahham
Sheikh Khalifa Medical City, UAE
Title: Challenges in managing heart failure with preserved ejection fraction (HFpEF)
Biography
Biography: Samer Ellahham
Abstract
Heart failure is a major cause of morbidity and mortality. It is important to discriminate between HFrEF and HFpEF. An array of evidence-based medical and device therapies are available to improve outcomes and alleviate symptoms in HFrEF. Treatment for HFpEF remains under active study.
The presentation will outline the difference between heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF). It will then state the difference between the pathophysiology, etiology, and clinical presentation of HFrEF and HFpEF. Finally the presentation will identify an individualized treatment plan for a patient with HFpEF utilizing current evidence. A team-based, collaborative approach is essential when patients have comorbid conditions and multiple healthcare providers.